Hot Gold Stocks To Buy For 2019

tags:CME,ORE,NGD,GSS,NXG,

The Securities and Exchange Commission is set to grant or deny approval of the Winklevoss Bitcoin Trust ETF, an exchange-traded fund that would track the value of digital currency bitcoin. Coming nearly four years – and a dozen amendments – after the fund was first proposed, the ruling could come as early as March 10 and make gaining access to the currency as easy as logging into your online brokerage account.

QUIZ: Test Your Knowledge of ETFs

Bitcoin is a so-called "cryptocurrency" – an encrypted digital currency created by computer programmers that can be exchanged electronically for goods and services. It serves as an alternative to traditional currencies, such as the U.S. dollar or the euro. For now, you can buy bitcoins on online exchanges, which often require an involved registration process and premium prices. Or you can "mine" them (create them), using extremely sophisticated computer codes. The value of a single bitcoin is determined by investor speculation. Worth almost nothing when it was created eight years ago, bitcoin hit a record high above $1,300 this week, topping the price of an ounce of gold. But the rise has been volatile, marked by steep dips that were triggered, in some cases, by high-profile hacks of online bitcoin exchanges.

Hot Gold Stocks To Buy For 2019: CME Group Inc.(CME)

Advisors' Opinion:

• [By Garrett Baldwin]
  Investors looking to make money on China should pay attention. While the United States is focusing this week on resolving issues with North Korea, the real elephant in the room remains China. President Trump has extended the artificial March 1 deadline on tariffs in hopes of striking a deal with the world's second largest economy. However, it remains very unclear what will happen in the coming weeks. Investors should prepare themselves accordingly. Money Morning Quantitative Specialist Chris Johnson has scoured the numbers and given investors a number of ways to make money on this massive geopolitical trend, right here. We are seeing some problems on the trading front from CME Group Inc. (NYSE: CME). The Chicago-based exchange operator halted trading for three hours Tuesday night after a glitch caused an outage. GME Globex is a massive platform that enables the trading of stocks, interest rates, forex exchange (currencies), commodities, and other assets. Pay close attention to the headlines, as it's still unclear if this was an internal issue or a cybersecurity event. Money Morning Insight of the Day

  According to Bloomberg's latest report, America could be heading for an economic disaster that would rival the Great Recession.

• [By Lee Jackson]

  This stock has had a solid 2018 and is a top pick at Deutsche Bank. CME Group Inc. (NASDAQ: CME) exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options. CME brings buyers and sellers together through its Globex electronic trading platform and its trading facilities in New York and Chicago.

• [By Stephan Byrd]

  Massachusetts Financial Services Co. MA cut its position in shares of CME Group (NASDAQ:CME) by 1.8% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 445,259 shares of the financial services provider’s stock after selling 7,975 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.13% of CME Group worth $72,016,000 as of its most recent filing with the SEC.

• [By Stephan Byrd]

  KAMES CAPITAL plc cut its position in CME Group Inc (NASDAQ:CME) by 1.7% in the third quarter, HoldingsChannel reports. The firm owned 511,147 shares of the financial services provider’s stock after selling 8,580 shares during the period. CME Group accounts for approximately 2.1% of KAMES CAPITAL plc’s investment portfolio, making the stock its 12th biggest holding. KAMES CAPITAL plc’s holdings in CME Group were worth $87,002,000 as of its most recent filing with the SEC.

• [By ]

  Case in point, I've held CME Group (NYSE: CME) in my High-Yield Investing portfolio for almost four years now. When I first took a position in the summer of 2014, the stock offered a regular quarterly dividend of $0.47 per share that added up to a modest yield of 2.6%. Many income investors skipped over it without a second glance.

Hot Gold Stocks To Buy For 2019: Orezone Gold Corp (ORE)

Advisors' Opinion:

• [By Peter Graham]

  Sandstorm's due diligence is thorough, they don't just invest in any company. They like West Africa because they understand the area and the opportunities that exist there. Sandstorm is a royalty and streaming company, so they make these investments and receive cashflow deals that often kick in much later on. But they have already established a presence in Burkina and have deals in place with larger companies like Orezone Gold (TSXV: ORE) and Endeavour Mining (TSX: EDV). Sandstorm's investment also potentially gives us access to their marketing department through something they call Launch Lab, and it looks like it will really benefit our own marketing efforts and will expose us to more opportunities over the coming year.

• [By Shane Hupp]

  Galactrum (ORE) is a PoW/PoS coin that uses the
  Lyra2RE hashing algorithm. It was first traded on December 13th, 2017. Galactrum’s total supply is 2,781,952 coins and its circulating supply is 2,061,952 coins. Galactrum’s official website is galactrum.org. Galactrum’s official Twitter account is @galactrum.

• [By Stephan Byrd]

  Galactrum (ORE) is a PoW/PoS coin that uses the
  Lyra2RE hashing algorithm. It launched on November 11th, 2017. Galactrum’s total supply is 2,092,679 coins and its circulating supply is 1,372,679 coins. Galactrum’s official Twitter account is @galactrum. Galactrum’s official website is galactrum.org.

• [By Jim Robertson]

  Finally, Richard Seville, the CEO of Brisbane-based Orocobre Ltd (ASX: ORE) which began lithium sales in 2015 from northern Argentina and also experienced difficulty boosting output, commented that an "inability to access traditional funds has delayed the development of the sector" and that "these projects aren't easy -- so the banks just don't want to go there."

• [By Stephan Byrd]

  Galactrum (CURRENCY:ORE) traded 1.7% lower against the U.S. dollar during the 24 hour period ending at 18:00 PM Eastern on August 31st. Galactrum has a total market capitalization of $866,847.00 and approximately $5,272.00 worth of Galactrum was traded on exchanges in the last 24 hours. One Galactrum coin can now be purchased for about $0.42 or 0.00006032 BTC on major exchanges including Stocks.Exchange and Cryptopia. In the last seven days, Galactrum has traded 12.5% higher against the U.S. dollar.

Hot Gold Stocks To Buy For 2019: NEW GOLD INC.(NGD)

Advisors' Opinion:

• [By Maxx Chatsko]

  Shares of New Gold (NYSEMKT:NGD) fell by over 14% today after the company announced the surprise sale of its Mesquite gold mine. The business will receive $158 million in cash for the productive asset, which management says will "immediately crystallize several years' worth of future free cash flow as part of our strategy to prudently manage our balance sheet, providing the company with the financial flexibility to focus on our core assets".

• [By Matthew DiLallo]

  Shares of New Gold (NYSEMKT:NGD) sold off on Thursday, plunging more than 20% by 11 a.m. EST after the gold mining company reported its fourth-quarter results as well as its outlook for 2019.

• [By Travis Hoium]

  Shares of miner New Gold Inc. (NYSEMKT:NGD) jumped as much as 19.4% in trading early Wednesday after the company announced a leadership change. Shares were hitting their high at 11:05 a.m. EDT and seemed to be gaining momentum.

• [By Shane Hupp]

  News articles about New Gold (NASDAQ:NGD) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. New Gold earned a news impact score of 0.01 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.1175522193993 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Hot Gold Stocks To Buy For 2019: Golden Star Resources Ltd(GSS)

Advisors' Opinion:

• [By Max Byerly]

  Golden Star Resources Ltd. (NYSEAMERICAN:GSS) was the target of a significant increase in short interest in September. As of September 28th, there was short interest totalling 10,021,831 shares, an increase of 6.9% from the September 14th total of 9,371,344 shares. Based on an average trading volume of 1,038,207 shares, the short-interest ratio is presently 9.7 days. Approximately 4.7% of the company’s shares are sold short.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Golden Star Resources (GSS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Get a free copy of the Zacks research report on Golden Star Resources (GSS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Get a free copy of the Zacks research report on Golden Star Resources (GSS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Golden Star Resources Ltd. (TSE:GSC) (NYSE:GSS) has been given an average recommendation of “Buy” by the six ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is C$1.48.

Hot Gold Stocks To Buy For 2019: Northgate Minerals Corporation(NXG)

Advisors' Opinion:

• [By Shane Hupp]

  Shares of NEX Group PLC (LON:NXG) have been given an average rating of “Hold” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is GBX 696 ($9.21).

Top Financial Stocks To Invest In 2019

tags:CLUB,INAP,ICLN,

Image source: The Motley Fool.

Magellan Midstream Partners (NYSE:MMP) Q4 2018 Earnings Conference CallJan. 31, 2019 1:30 p.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Magellan Midstream Partners fourth-quarter 2018 earnings results conference call. [Operator instructions] As a reminder, this conference is being recorded today, Thursday, January 31, 2019. And now, it's my pleasure to turn the call over to Mike Mears, chief executive officer. Please go ahead, sir.

Mike Mears -- Chief Executive Officer

Great. Thank you. Good afternoon, and thank you for joining us today to discuss Magellan's fourth-quarter financial results and our outlook for 2019. Before we get started, I'll remind you that management will be making forward-looking statements as defined by the SEC.

Top Financial Stocks To Invest In 2019: Town Sports International Holdings, Inc.(CLUB)

Advisors' Opinion:

• [By Stephan Byrd]

  Town Sports International Holdings, Inc. (NASDAQ:CLUB) insider Pw Partners Atlas Fund Iii, Lp bought 2,806 shares of the firm’s stock in a transaction on Thursday, June 14th. The stock was purchased at an average price of $11.60 per share, with a total value of $32,549.60. Following the transaction, the insider now owns 1,503,448 shares in the company, valued at approximately $17,439,996.80. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

• [By Shane Hupp]

  ClubCoin (CURRENCY:CLUB) traded up 24.9% against the dollar during the 1 day period ending at 10:00 AM Eastern on August 28th. One ClubCoin coin can currently be purchased for approximately $0.63 or 0.00008900 BTC on cryptocurrency exchanges. In the last seven days, ClubCoin has traded 78.8% higher against the dollar. ClubCoin has a total market capitalization of $0.00 and approximately $67,516.00 worth of ClubCoin was traded on exchanges in the last day.

• [By Stephan Byrd]

  ClubCoin (CURRENCY:CLUB) traded 1.9% higher against the US dollar during the twenty-four hour period ending at 0:00 AM Eastern on February 2nd. One ClubCoin coin can now be purchased for about $0.37 or 0.00010522 BTC on popular exchanges including Trade Satoshi and YoBit. ClubCoin has a market capitalization of $0.00 and $15,235.00 worth of ClubCoin was traded on exchanges in the last day. During the last seven days, ClubCoin has traded down 5.3% against the US dollar.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Town Sports International (CLUB)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  COPYRIGHT VIOLATION NOTICE: “Town Sports International (CLUB) Rating Reiterated by Imperial Capital” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.tickerreport.com/banking-finance/3370451/town-sports-international-club-rating-reiterated-by-imperial-capital.html.

• [By Logan Wallace]

  ClubCoin (CURRENCY:CLUB) traded up 18.2% against the dollar during the one day period ending at 16:00 PM E.T. on July 20th. One ClubCoin coin can now be purchased for about $0.66 or 0.00009000 BTC on exchanges. In the last seven days, ClubCoin has traded up 41.8% against the dollar. ClubCoin has a total market capitalization of $0.00 and $11,282.00 worth of ClubCoin was traded on exchanges in the last day.

Top Financial Stocks To Invest In 2019: Internap Network Services Corporation(INAP)

Advisors' Opinion:

• [By Stephan Byrd]

  Internap Corp (NASDAQ:INAP) has received an average rating of “Buy” from the six analysts that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating, one has issued a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $28.00.

• [By Ethan Ryder]

  Shares of Internap Corp (NASDAQ:INAP) saw unusually-strong trading volume on Tuesday . Approximately 1,086,029 shares traded hands during mid-day trading, an increase of 306% from the previous session’s volume of 267,673 shares.The stock last traded at $5.85 and had previously closed at $5.32.

• [By Stephan Byrd]

  Internap (NASDAQ:INAP) issued its quarterly earnings data on Thursday. The information technology services provider reported ($0.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.13), MarketWatch Earnings reports. The business had revenue of $74.20 million for the quarter, compared to analyst estimates of $73.99 million. Internap had a negative return on equity of 271.76% and a negative net margin of 16.15%. The firm’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.02) earnings per share.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Internap (INAP)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Internap (INAP)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  GDS (NASDAQ: INAP) and Internap (NASDAQ:INAP) are both business services companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.

Top Financial Stocks To Invest In 2019: iShares S&P Global Clean Energy Index Fund(ICLN)

Advisors' Opinion:

• [By Scott Levine]

  For those afraid of getting burned with the solar ETF, the iShares Global Clean Energy ETF (NASDAQ:ICLN) may be a more attractive option since the fund's stated objective is to "track the investment results of the S&P Global Clean Energy Index." The fund's 30 holdings represent global leaders in renewable energy, ranging from solar power to geothermal to waste-to-energy. Like the Invesco Solar ETF, the iShares Global Clean Energy ETF is not actively managed and carries a fairly low expense ratio of 0.47%. Distributions are made semiannually and currently offer a trailing-12-month yield of 2.34%.

Top 10 Warren Buffett Stocks To Own Right Now

tags:EIA,CRME,LL,HMSY,CHSCL,BAMM,ESRT,MGV,USA,CLMT,

On July 17, Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) announced a change to its share repurchase program:

"The earlier share repurchase program provided that the price paid for repurchases would not exceed a 20% premium over the then-current book value of such shares. Under the amendment adopted by the Board of Directors, share repurchases can be made at any time that both Warren Buffett, Berkshire's Chairman and CEO, and Charlie Munger, a Berkshire Vice Chairman, believe that the repurchase price is below Berkshire's intrinsic value, conservatively determined."  

Of course, Berkshire didn't report any repurchases in its recent second quarter report, since the quarter ended two weeks prior to the announcement. So, did Buffett and Munger decide to loosen the purse strings on Berkshire's cash pile randomly, or did the announcement signal they want to start buying shares right now? Though the stock sits near all-time highs, I think it's entirely possible Berkshire is repurchasing its shares at this very moment.

Top 10 Warren Buffett Stocks To Own Right Now: Eaton Vance California Municipal Bond Fund II(EIA)

Advisors' Opinion:

• [By Joseph Griffin]

  Eaton Vance California Municpl Bnd Fd II (NYSEAMERICAN:EIA) announced a monthly dividend on Monday, June 4th, Wall Street Journal reports. Shareholders of record on Friday, June 22nd will be given a dividend of 0.0442 per share by the closed-end fund on Friday, June 29th. This represents a $0.53 annualized dividend and a yield of 4.89%. The ex-dividend date is Thursday, June 21st.

Top 10 Warren Buffett Stocks To Own Right Now: Cardiome Pharma Corporation(CRME)

Advisors' Opinion:

• [By Logan Wallace]

  Cardiome Pharma Co. (TSE:COM) (NASDAQ:CRME) – Stock analysts at Zacks Investment Research issued their Q2 2018 EPS estimates for Cardiome Pharma in a research note issued on Tuesday, May 22nd. Zacks Investment Research analyst J. Vandermosten anticipates that the biopharmaceutical company will post earnings per share of ($0.26) for the quarter.

• [By Stephan Byrd]

  Here are some of the media stories that may have impacted Accern’s rankings:

  Get Cardiome Pharma alerts: Cardiome Pharma Corp (TSE:COM): Should The Recent Earnings Drop Worry You? (finance.yahoo.com) Pacira Pharmaceuticals Gets a Hold Rating from Canaccord Genuity (analystratings.com) As of May, 21 Analysts See $-0.20 EPS for Cardiome Pharma Corp. (CRME) (thecasualsmart.com) Cardiome Pharma Corp. (CRME) stock added 0.33% off its SMA-20 (thestocksnews.com) Cardiome Pharma (CRME) Upgraded to Sell at ValuEngine (americanbankingnews.com)

  Shares of CRME traded down $0.01 during mid-day trading on Wednesday, reaching $2.29. The company’s stock had a trading volume of 730 shares, compared to its average volume of 138,610. The firm has a market cap of $80.20 million, a price-to-earnings ratio of -2.53 and a beta of 0.19. The company has a debt-to-equity ratio of 2.47, a quick ratio of 3.99 and a current ratio of 4.80. Cardiome Pharma has a 52 week low of $2.28 and a 52 week high of $2.30.

• [By Lisa Levin]

  Cardiome Pharma Corp. (NASDAQ: CRME) is expected to post quarterly loss at $0.07 per share on revenue of $6.34 million.

  Quest Resource Holding Corporation (NASDAQ: QRHC) is estimated to post quarterly loss at $0.09 per share on revenue of $24.85 million.

Top 10 Warren Buffett Stocks To Own Right Now: Lumber Liquidators Holdings, Inc(LL)

Advisors' Opinion:

• [By Neha Chamaria]

  Lumber Liquidators (NYSE:LL) shares fell through the floor in the first quarter of the year, losing more than one-third in value; they regained some ground to end the first half of 2018 down 22.4%, according to data provided by S&P Global Market Intelligence. Going by the stock's recovery in the past couple of months -- July has also been strong so far -- it seems investors are betting on better days ahead for the flooring retailer.

• [By Motley Fool Transcribers]

  Lumber Liquidators Holdings Inc  (NYSE:LL)Q4 2018 Earnings Conference CallMarch 18, 2019, 8:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Ethan Ryder]

  Lumber Liquidators Holdings (NYSE:LL) – Oppenheimer upped their FY2018 earnings per share (EPS) estimates for shares of Lumber Liquidators in a report issued on Tuesday, May 1st. Oppenheimer analyst B. Nagel now forecasts that the specialty retailer will post earnings of $0.80 per share for the year, up from their prior estimate of $0.70.

Top 10 Warren Buffett Stocks To Own Right Now: HMS Holdings Corp(HMSY)

Advisors' Opinion:

• [By Logan Wallace]

  Massachusetts Financial Services Co. MA increased its position in shares of HMS Holdings (NASDAQ:HMSY) by 40.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,007,174 shares of the business services provider’s stock after purchasing an additional 292,456 shares during the period. Massachusetts Financial Services Co. MA owned approximately 1.21% of HMS worth $16,961,000 as of its most recent filing with the Securities and Exchange Commission.

• [By Max Byerly]

  HMS Holdings Corp (NASDAQ:HMSY) has been assigned an average recommendation of “Buy” from the thirteen analysts that are currently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $30.90.

• [By Lisa Levin] Gainers Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday. Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings. Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744. Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share. Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban. Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results. California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings. Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results. Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance. Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46. Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results. Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter. Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36. Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings. Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result
• [By Max Byerly]

  Macquarie Group Ltd. raised its stake in shares of HMS Holdings Corp (NASDAQ:HMSY) by 344.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 8,000 shares of the business services provider’s stock after buying an additional 6,200 shares during the period. Macquarie Group Ltd.’s holdings in HMS were worth $173,000 as of its most recent SEC filing.

• [By Logan Wallace]

  HMS Holdings Corp (NASDAQ:HMSY) has earned an average recommendation of “Buy” from the eleven analysts that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $30.13.

• [By Logan Wallace]

  COPYRIGHT VIOLATION WARNING: “Cigna Investments Inc. New Raises Position in HMS Holdings Corp (HMSY)” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://www.tickerreport.com/banking-finance/4158664/cigna-investments-inc-new-raises-position-in-hms-holdings-corp-hmsy.html.

Top 10 Warren Buffett Stocks To Own Right Now: CHS Inc(CHSCL)

Advisors' Opinion:

• [By Joseph Griffin]

  CHS (NASDAQ:CHSCL) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Friday.

Top 10 Warren Buffett Stocks To Own Right Now: Books-A-Million Inc.(BAMM)

Advisors' Opinion:

• [By Joseph Griffin]

  News articles about Books-A-Million (NASDAQ:BAMM) have trended positive recently, according to Accern. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Books-A-Million earned a coverage optimism score of 0.27 on Accern’s scale. Accern also gave news articles about the specialty retailer an impact score of 44.3915244007427 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 Warren Buffett Stocks To Own Right Now: Empire State Realty Trust, Inc.(ESRT)

Advisors' Opinion:

• [By Logan Wallace]

  Citadel Advisors LLC grew its holdings in Empire State Realty Trust Inc (NYSE:ESRT) by 109.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,444,342 shares of the real estate investment trust’s stock after purchasing an additional 1,801,601 shares during the quarter. Citadel Advisors LLC’s holdings in Empire State Realty Trust were worth $58,899,000 at the end of the most recent reporting period.

• [By ]

  For example, nobody is going to come along and build another Empire State Building. In fact, you can actually invest in this building through the Empire State Realty Trust (NYSE: ESRT). 

• [By Matthew Frankel, CFP]

  With all of that in mind, here's why I think Realty Income (NYSE:O) and Empire State Realty Trust (NYSE:ESRT) make excellent IRA investments. In fact, I hold both in my retirement portfolio.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Empire State Realty Trust (ESRT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks To Own Right Now: Vanguard Mega Cap Value ETF (MGV)

Advisors' Opinion:

• [By Shane Hupp]

  Baird Financial Group Inc. purchased a new stake in Vanguard Mega Cap Value ETF (NYSEARCA:MGV) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 10,229 shares of the company’s stock, valued at approximately $761,000.

Top 10 Warren Buffett Stocks To Own Right Now: Liberty All-Star Equity Fund(USA)

Advisors' Opinion:

• [By ]

  Given that the Fed has indicated it would welcome a modest overshoot in inflation, markets would likely need to see wages grow by 0.4 percent or 0.5 percent to gain confidence in a fourth 2018 hike, according to Priya Misra, head of global rates strategy at TD Securities (USA) LLC.

• [By ]

  These are the participating banks:

  In the U.S.: Ally Financial, American Express, Bank of America, Bank of New York Mellon, BB&T, Capital One, CIT, Citigroup, Citizens Financial, Comerica, Discover Financial, Fifth Third, Goldman Sachs, Huntington, JPMorgan Chase, KeyBanc, M&T, Morgan Stanley, Northern Trust, PNC Financial, Regions Financial, State Street, SunTrust, U.S. Bancorp, Wells Fargo, and Zions. Non-U.S. firms: Barclays US, BBVA Compass Bancshares, BMO Financial, BNP Paribas USA, Credit Suisse Holdings (USA), Deutsche Bank USA, HSBC North America Holdings, MUFG Americas Holdings, RBC USA, Santander Holdings USA, TD Group US, UBS Americas

  Here’s a sample of recent analyst commentary:

Top 10 Warren Buffett Stocks To Own Right Now: Calumet Specialty Products Partners L.P.(CLMT)

Advisors' Opinion:

• [By Reuben Gregg Brewer]

  Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) and Delek US Holdings, Inc. (NYSE:DL) have both witnessed large stock advances over the past year. However, the performances of these chemical and refining companies have started to diverge somewhat over the past few months. There's a good reason for this, but does that make Delek, the better performer this year, the better stock for investors?

• [By Max Byerly]

  Get a free copy of the Zacks research report on Calumet Specialty Products Partners, L.P (CLMT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Tyler Crowe]

  Whenever a company is in the midst of a multiyear turnaround plan like Calumet Specialty Products Partners (NASDAQ:CLMT), some quarters are going to show more progress than others. This past quarter was one of those less noticeable quarters as many of the moves it made were a detriment to the bottom line. Nevertheless, there were some reasons investors should be satisfied with what Calumet did in the quarter.

Hot Biotech Stocks To Own For 2019

tags:ALNY,BIIB,ARQL,AMGN,

News stories about NewLink Genetics (NASDAQ:NLNK) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. NewLink Genetics earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave media stories about the biotechnology company an impact score of 45.8843226822969 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Shares of NewLink Genetics traded down $0.06, reaching $5.10, during trading hours on Friday, according to MarketBeat. The company had a trading volume of 1,768,300 shares, compared to its average volume of 952,710. The company has a market capitalization of $196.23 million, a PE ratio of -2.22 and a beta of 1.25. NewLink Genetics has a 12-month low of $3.75 and a 12-month high of $19.30.

Hot Biotech Stocks To Own For 2019: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Alnylam Pharmaceuticals (ALNY)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Get a free copy of the Zacks research report on Alnylam Pharmaceuticals (ALNY)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Keith Speights]

  It's not exactly David vs. Goliath. However, Bellicum Pharmaceuticals (NASDAQ:BLCM) and Alnylam Pharmaceuticals (NASDAQ:ALNY) are definitely in different leagues right now. Both are clinical-stage biotechs, but Bellicum's market cap is less than $350 million while Alnylam's market cap is close to $10 billion.

• [By Sean Williams, Chuck Saletta, and Brian Feroldi]

  So, which biotech stocks should you consider buying in June? That's a question we posed to three of our healthcare-focused investors. Interestingly enough, mid-cap biotech stocks are the clear flavor of the month. If biotech is on your radar in June, our investors suggest you consider Ionis Pharmaceuticals (NASDAQ:IONS), Spark Therapeutics (NASDAQ:ONCE), and Alnylam Pharmaceuticals (NASDAQ:ALNY).

• [By Max Byerly]

  Alnylam Pharmaceuticals (NASDAQ:ALNY) last issued its quarterly earnings results on Thursday, May 3rd. The biopharmaceutical company reported ($1.41) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.06. The business had revenue of $21.90 million during the quarter, compared to analysts’ expectations of $35.23 million. Alnylam Pharmaceuticals had a negative return on equity of 36.81% and a negative net margin of 565.20%. The business’s quarterly revenue was up 15.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($1.25) earnings per share. equities analysts anticipate that Alnylam Pharmaceuticals, Inc. will post -6.7 earnings per share for the current fiscal year.

• [By Cory Renauer]

  If approved, Tegsedi will run directly into competition with Alnylam's (NASDAQ:ALNY) recently approved treatment for the limited population of ATTR patients, Onpattro. Inotersen and Onpattro haven't been tested in a head-to-head study, but most analysts expect Alnylam's drug to gain a much larger share of the limited space than Akcea's.

Hot Biotech Stocks To Own For 2019: Biogen Idec Inc(BIIB)

Advisors' Opinion:

• [By Cory Renauer]

  Biogen Inc. (NASDAQ:BIIB) and Gilead Sciences, Inc. (NASDAQ:GILD) were two of biotech's best-performing stocks in years past, but investors are a lot more worried about where they're going right now. Gilead Sciences has a new management team and a new focus on treating cancer. Now that competitors have diminished Biogen's dominance in the multiple sclerosis space, the company's taking bold steps as well.

• [By Chris Lange]

  Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 4.33 million shares from the previous 3.86 million. The stock recently traded at $306.68 within a 52-week range of $249.17 to $370.57.

• [By Chris Lange]

  Biogen Inc.’s (NASDAQ: BIIB) second-quarter report is scheduled for Tuesday before the markets open. The consensus estimates are $5.24 in earnings per share (EPS) on $3.26 billion in revenue. The shares ended the week trading at $357.56. The consensus price target is $367.08, and the 52-week trading range is $249.17 to $370.57.

• [By Chris Lange]

  Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 4.00 million shares from the previous 3.91 million. The stock recently traded at $346.90, within a 52-week range of $249.17 to $388.67.

• [By Chris Lange]

  Nightstar Therapeutics PLC (NASDAQ: NITE) shares exploded early on Monday after it was announced that the firm would be acquired by Biogen Inc. (NASDAQ: BIIB). The transaction is expected to close by mid-year 2019.

• [By Dan Caplinger]

  Wall Street continued its downward streak on Monday, with the Dow Jones Industrial Average falling more than 100 points. Most major benchmarks fell more modestly, with a few actually poking into positive territory on the day. Trade-sensitive stocks were among the weakest as investors focused on uncertainty related to tariff disputes between the U.S. and China. But for some other companies, bad news of a different sort was responsible for the drops in their shares. Biogen (NASDAQ:BIIB), Baytex Energy (NYSE:BTE), and Catalyst Biosciences (NASDAQ:CBIO) were among the worst performers on the day. Here's why they did so poorly.

Hot Biotech Stocks To Own For 2019: ArQule Inc.(ARQL)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on ArQule (ARQL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Cory Renauer]

  What's behind these dramatic gains? Read on to find out.

  Company Gain in H1 2018 Market Cap Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) 270% $1.19 billion ArQule, Inc. (NASDAQ:ARQL) 235% $482 million Endocyte, Inc. (NASDAQ:ECYT) 222% $959 million Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) 205% $3.99 billion

  Data source: YCharts.

• [By Motley Fool Transcribers]

  Arqule Inc  (NASDAQ:ARQL)Q4 2018 Earnings Conference CallMarch 07, 2019, 9:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on ArQule (ARQL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Money Morning Staff Reports]

  But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we'll show you a small-cap stock with great profit potential in its future…

  Penny Stock Current Share Price Law Month's Gain  Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85% Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40% Vivis Inc. (Nasdaq: VVUS) $0.77 150.41% Adomani Inc. (Nasdaq: ADOM) $1.49 137.68% NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88% Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06% Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12% ArQule Inc. (Nasdaq: ARQL) $4.88 90.74% LiqTech International Inc. (NYSE: LIQT) $0.66 85.60% Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

  While last month's gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

• [By Stephan Byrd]

  ArQule, Inc. (NASDAQ:ARQL) Director Ronald M. Lindsay acquired 23,900 shares of the company’s stock in a transaction on Thursday, May 10th. The stock was acquired at an average price of $2.67 per share, for a total transaction of $63,813.00. Following the purchase, the director now directly owns 43,900 shares of the company’s stock, valued at $117,213. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Hot Biotech Stocks To Own For 2019: Amgen Inc.(AMGN)

Advisors' Opinion:

• [By Cory Renauer]

  Sanofi took the assessment and started engaging end payers to see if any would offer easy reimbursement for a lower net price that reflects ICER's assessment, and the industry listened. As of July 1, the partners will cut the net price of Praluent in return for straightforward access for around 25 million Americans covered by the Express Scripts (NASDAQ:ESRX) national formulary. The pharmacy benefits manager, and will also remove formulary access for its main competitor, Amgen's (NASDAQ:AMGN) Repatha.

• [By Todd Campbell]

  Neulasta has been one of Amgen's (NASDAQ:AMGN) crown jewels for years, but following FDA approval of Mylan's (NASDAQ:MYL) Neulasta biosimilar this week, Amgen could see Neulasta's revenue slow to a trickle. Is Mylan about to deliver a big blow to Amgen's market share? Read on to find out what's at stake for these companies and their investors.

• [By Chris Lange]

  Amgen Inc. (NASDAQ: AMGN) saw its short interest fall to 10.24 million shares from the previous level of 10.63 million. Shares were last seen trading at $206.00, in a 52-week trading range of $163.31 to $210.19.

• [By Cory Renauer]

  With Johnson & Johnson picking up the tab for ARO-HPV, Arrowhead can direct more resources toward candidates it still owns outright. Although Arrowhead has several preclinical stage candidates that could begin their first human studies soon, just two other candidates are in their first clinical trials right now, a wholly owned candidate for the treatment alpha-1 antitrypsin deficiency (AATD), and a cardiology drug partnered with Amgen (NASDAQ:AMGN).  

• [By Stephan Byrd]

  Marco Investment Management LLC raised its holdings in shares of Amgen, Inc. (NASDAQ:AMGN) by 4.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 118,601 shares of the medical research company’s stock after buying an additional 5,265 shares during the period. Amgen comprises approximately 3.4% of Marco Investment Management LLC’s portfolio, making the stock its 3rd largest position. Marco Investment Management LLC’s holdings in Amgen were worth $21,893,000 as of its most recent SEC filing.

• [By Todd Campbell]

  When a brand new class of cholesterol-lowering drugs called PCSK9 inhibitors won Food and Drug Administration (FDA) approval in 2015, it was heralded as the biggest advance in battling heart disease since the invention of statins. The launch of PCSK9 inhibitors was accompanied by billion-dollar-plus predictions for sales. However, revenue has fallen far shy of blockbuster status, leaving drugmakers Amgen Inc. (NASDAQ:AMGN), Regeneron Pharmaceuticals (NASDAQ:REGN), and Sanofi SA (NYSE:SNY) in the lurch.

Los Angeles Capital Management & Equity Research Inc. Sells 3,570 Shares of Edgewell Personal C

Los Angeles Capital Management & Equity Research Inc. reduced its position in Edgewell Personal Care Co (NYSE:EPC) by 17.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,516 shares of the company’s stock after selling 3,570 shares during the quarter. Los Angeles Capital Management & Equity Research Inc.’s holdings in Edgewell Personal Care were worth $617,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. CX Institutional purchased a new stake in Edgewell Personal Care in the fourth quarter worth $42,000. Eukles Asset Management purchased a new stake in Edgewell Personal Care in the fourth quarter worth $77,000. Strs Ohio increased its position in Edgewell Personal Care by 46.7% in the fourth quarter. Strs Ohio now owns 2,200 shares of the company’s stock worth $82,000 after buying an additional 700 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Edgewell Personal Care by 17.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,797 shares of the company’s stock worth $142,000 after buying an additional 554 shares during the last quarter. Finally, Quantamental Technologies LLC purchased a new stake in Edgewell Personal Care in the fourth quarter worth $149,000. 95.48% of the stock is owned by institutional investors and hedge funds.

Get Edgewell Personal Care alerts:

Edgewell Personal Care stock opened at $43.21 on Thursday. Edgewell Personal Care Co has a one year low of $35.85 and a one year high of $59.16. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.46 and a quick ratio of 0.87. The firm has a market capitalization of $2.36 billion, a PE ratio of 11.76, a P/E/G ratio of 4.72 and a beta of 0.70.

Edgewell Personal Care (NYSE:EPC) last posted its quarterly earnings results on Thursday, February 7th. The company reported $0.37 EPS for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.15. Edgewell Personal Care had a return on equity of 11.57% and a net margin of 4.33%. The firm had revenue of $457.00 million during the quarter, compared to analyst estimates of $445.53 million. During the same period last year, the company earned $0.20 earnings per share. The business’s revenue for the quarter was down 2.4% on a year-over-year basis. Analysts anticipate that Edgewell Personal Care Co will post 3.4 EPS for the current fiscal year.

A number of analysts have issued reports on EPC shares. Zacks Investment Research downgraded Edgewell Personal Care from a “hold” rating to a “sell” rating in a research report on Wednesday, November 14th. Deutsche Bank decreased their target price on Edgewell Personal Care from $49.00 to $43.00 and set a “hold” rating for the company in a research report on Wednesday, November 14th. Bank of America raised Edgewell Personal Care from an “underperform” rating to a “neutral” rating and set a $46.00 target price for the company in a research report on Friday, February 8th. ValuEngine raised Edgewell Personal Care from a “strong sell” rating to a “sell” rating in a research report on Wednesday, February 13th. Finally, Barclays set a $39.00 target price on Edgewell Personal Care and gave the stock a “sell” rating in a research report on Monday, November 19th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company’s stock. Edgewell Personal Care currently has an average rating of “Hold” and an average price target of $46.45.

ILLEGAL ACTIVITY WARNING: “Los Angeles Capital Management & Equity Research Inc. Sells 3,570 Shares of Edgewell Personal Care Co (EPC)” was originally published by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/4219996/los-angeles-capital-management-equity-research-inc-sells-3570-shares-of-edgewell-personal-care-co-epc.html.

Edgewell Personal Care Profile

Edgewell Personal Care Company is a manufacturer and marketer of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. As of September 30, 2016, the Company had a portfolio of over 25 brands. It manages its business in four segments: Wet Shave, Sun and Skin Care, Feminine Care and All Other.

Featured Article: What is the quiet period?

Investors Sell Shares of SPDR Bloomberg Barclays High Yield Bond ETF (JNK) on Strength (JNK)

Traders sold shares of SPDR Bloomberg Barclays High Yield Bond ETF (NYSEARCA:JNK) on strength during trading on Tuesday. $36.32 million flowed into the stock on the tick-up and $119.69 million flowed out of the stock on the tick-down, for a money net flow of $83.37 million out of the stock. Of all companies tracked, SPDR Bloomberg Barclays High Yield Bond ETF had the 24th highest net out-flow for the day. SPDR Bloomberg Barclays High Yield Bond ETF traded up $0.07 for the day and closed at $35.57

The company also recently announced a monthly dividend, which was paid on Thursday, March 7th. Stockholders of record on Monday, March 4th were given a dividend of $0.1734 per share. The ex-dividend date was Friday, March 1st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 5.85%. This is a boost from SPDR Bloomberg Barclays High Yield Bond ETF’s previous monthly dividend of $0.17.

Get SPDR Bloomberg Barclays High Yield Bond ETF alerts:

Several institutional investors and hedge funds have recently bought and sold shares of the company. Bank of America Corp DE increased its position in shares of SPDR Bloomberg Barclays High Yield Bond ETF by 8.4% during the fourth quarter. Bank of America Corp DE now owns 18,046,152 shares of the exchange traded fund’s stock worth $606,170,000 after purchasing an additional 1,394,089 shares in the last quarter. Assetmark Inc. increased its position in SPDR Bloomberg Barclays High Yield Bond ETF by 9.3% in the 3rd quarter. Assetmark Inc. now owns 7,472,693 shares of the exchange traded fund’s stock valued at $269,391,000 after acquiring an additional 637,248 shares during the period. BlackRock Inc. increased its position in SPDR Bloomberg Barclays High Yield Bond ETF by 26.7% in the 4th quarter. BlackRock Inc. now owns 7,000,827 shares of the exchange traded fund’s stock valued at $235,158,000 after acquiring an additional 1,477,414 shares during the period. JPMorgan Chase & Co. increased its position in SPDR Bloomberg Barclays High Yield Bond ETF by 18.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 6,143,289 shares of the exchange traded fund’s stock valued at $221,466,000 after acquiring an additional 938,559 shares during the period. Finally, United Services Automobile Association increased its position in SPDR Bloomberg Barclays High Yield Bond ETF by 43.9% in the 3rd quarter. United Services Automobile Association now owns 4,837,880 shares of the exchange traded fund’s stock valued at $174,406,000 after acquiring an additional 1,477,040 shares during the period.

TRADEMARK VIOLATION WARNING: “Investors Sell Shares of SPDR Bloomberg Barclays High Yield Bond ETF (JNK) on Strength (JNK)” was first published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/4216581/investors-sell-shares-of-spdr-bloomberg-barclays-high-yield-bond-etf-jnk-on-strength-jnk.html.

SPDR Bloomberg Barclays High Yield Bond ETF Company Profile (NYSEARCA:JNK)

SPDR Barclays High Yield Bond ETF (the Fund), formerly SPDR Barclays Capital High Yield Bond ETF, seeks to provide investment results that correspond to the price and yield performance of the Barclays Capital High Yield Very Liquid Index (the Index). The Index includes publicly issued United States dollar denominated, non-investment grade, fixed-rate, taxable corporate bonds that have a remaining maturity of at least one year, regardless of optionality, are rated high-yield using the middle rating of Moody's, S&P, and Fitch, respectively, and have $600 million or more of outstanding face value.

Read More: What Factors Can Affect Return on Equity?

Best Warren Buffett Stocks To Own For 2019

tags:OSBC,MLHR,TREE,RMTI,CSWC,

As far as we know, he's the only undefeated individual in this entire industry.

If he has to scrutinize every number on every SEC filing that a company has ever made – until he feels comfortable enough betting his life that the stock will go up…

Then that's exactly what he'll do!

This isn't a side job or hobby for him. It's his livelihood.

He doesn't buy into hyperbolic nonsense. He doesn't listen to 30-year-old MBAs who think that because they took a class in microeconomics, they know the future.

NO ONE – We don't care if you're a wizard with enchanted powers or Warren Buffett's third cousin…

Best Warren Buffett Stocks To Own For 2019: Old Second Bancorp Inc.(OSBC)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Old Second Bancorp (OSBC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Old Second Bancorp (OSBC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Warren Buffett Stocks To Own For 2019: Herman Miller, Inc.(MLHR)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Herman Miller (MLHR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Get a free copy of the Zacks research report on Herman Miller (MLHR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Asit Sharma]

  High-end office furniture manufacturer Herman Miller, Inc. (NASDAQ:MLHR) released fiscal fourth-quarter 2018 earnings on Monday after the markets closed, and in the following Tuesday trading session, the company's shares jumped nearly 11%. Let's review the factors driving investors' warm enthusiasm after taking in the headline numbers below.

Best Warren Buffett Stocks To Own For 2019: Tree.com Inc.(TREE)

Advisors' Opinion:

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Lendingtree (TREE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Rhumbline Advisers decreased its position in LendingTree (NASDAQ:TREE) by 13.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,988 shares of the financial services provider’s stock after selling 2,252 shares during the period. Rhumbline Advisers’ holdings in LendingTree were worth $4,590,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

• [By Demitrios Kalogeropoulos]

  Shares of consumer lending specialist LendingTree (NASDAQ:TREE) spiked 35% last month, trouncing the S&P 500's 8% gain, according to data provided by S&P Global Market Intelligence.

Best Warren Buffett Stocks To Own For 2019: Rockwell Medical Technologies Inc.(RMTI)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on Rockwell Medical (RMTI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Zoe's Kitchen, Inc. (NYSE: ZOES) fell 27.8 percent to $10.45 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter. The company also lowered its FY18 sales outlook from $358million-$368 million to $345 million-$352 million. Hibbett Sports, Inc. (NASDAQ: HIBB) shares fell 15.6 percent to $24.50 in pre-market trading after the company reported weaker-than-expected results for its first quarter. Rockwell Medical, Inc. (NASDAQ: RMTI) fell 15.5 percent to $5.02 in the pre-market trading session after the company disclosed that its President and CEO Robert Chioini was terminated. BG Staffing Inc (NYSE: BGSF) shares fell 12.7 percent to $19.00 in pre-market trading after reporting a common stock offering. 8x8, Inc. (NASDAQ: EGHT) fell 9.3 percent to $20.00 in pre-market trading after reporting downbeat quarterly earnings. Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) fell 7.7 percent to $2.35 in pre-market trading after rising 3.88 percent on Thursday. Gap, Inc. (NYSE: GPS) shares fell 7.5 percent to $30.49 in pre-market trading after the company posted downbeat earnings for its first quarter on Thursday. Comps were up 1 percent in the quarter. California Resources Corporation (NYSE: CRC) fell 6.4 percent to $33.91 in pre-market trading. Buckle Inc (NYSE: BKE) fell 4.9 percent to $24.50 in pre-market trading following weak quarterly sales. China Rapid Finance Limited (NYSE: XRF) shares fell 4.9 percent to $3.13 in pre-market trading after climbing 11.53 percent on Thursday. Ross Stores, Inc. (NASDAQ: ROST) fell 4.8 percent to $78.98 in pre-market trading. Ross Stores reported upbeat earnings for its first quarter, but issued weak forecast for the current quarter. Callon Petroleum Company (NYSE: CPE) shares fell 4.7 percent to $11.90 in pre-market trading after the company reported pricing of common
• [By Max Byerly]

  Rockwell Medical (NASDAQ:RMTI) last issued its earnings results on Tuesday, August 14th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.09). Rockwell Medical had a negative return on equity of 89.63% and a negative net margin of 55.38%. The company had revenue of $14.91 million during the quarter, compared to analyst estimates of $14.90 million. equities analysts expect that Rockwell Medical Inc will post -0.59 EPS for the current year.

Best Warren Buffett Stocks To Own For 2019: Capital Southwest Corporation(CSWC)

Advisors' Opinion:

• [By Stephan Byrd]

  Press coverage about Capital Southwest (NASDAQ:CSWC) has been trending positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Capital Southwest earned a coverage optimism score of 0.27 on Accern’s scale. Accern also assigned news stories about the asset manager an impact score of 44.9331419606621 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

• [By Joseph Griffin]

  Capital Southwest Co. (NASDAQ:CSWC) announced a quarterly dividend on Tuesday, June 5th, Wall Street Journal reports. Investors of record on Tuesday, June 26th will be paid a dividend of 0.29 per share by the asset manager on Monday, July 2nd. This represents a $1.16 annualized dividend and a dividend yield of 6.80%. The ex-dividend date of this dividend is Monday, June 25th. This is a boost from Capital Southwest’s previous quarterly dividend of $0.28.

• [By Max Byerly]

  Capital Southwest (NASDAQ: CSWC) and TRIPLEPOINT VEN/COM (NYSE:TPVG) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

• [By Motley Fool Transcribers]

  Capital Southwest Corp  (NASDAQ:CSWC)Q3 2019 Earnings Conference CallFeb. 05, 2019, 11:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Logan Wallace]

  Advisors Asset Management Inc. decreased its stake in shares of Capital Southwest Co. (NASDAQ:CSWC) by 5.6% in the 2nd quarter, Holdings Channel reports. The firm owned 82,556 shares of the asset manager’s stock after selling 4,935 shares during the quarter. Advisors Asset Management Inc.’s holdings in Capital Southwest were worth $2,164,000 at the end of the most recent quarter.

• [By Motley Fool Staff]

  Capital Southwest (NASDAQ:CSWC) Q4 2018 Earnings Conference CallJun. 5, 2018 11:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Roth IRA or Traditional IRA: Which One Is Right for You?

When it comes to saving for retirement, you have several options for where to stash your cash. If your company offers a 401(k) plan, you may choose to go that route and simply contribute a portion of each paycheck to your retirement savings.

What if you don't have a 401(k), though? Only 59% of American employees have access to a defined contribution plan like a 401(k), according to the Bureau of Labor Statistics, which means a good chunk of workers are on their own when it comes to funding a retirement account.

Image source: Getty Images.

The most common solution is to open an IRA, or individual retirement account. But there are several different types of IRAs to choose from, the most popular being Roth IRAs and traditional IRAs. Although they're similar in many ways, they do have key differences. And it's important to understand those differences before deciding which one is right for you.

Traditional vs. Roth: What's the difference?

The biggest difference between traditional IRAs and Roth IRAs is how they're taxed. With a traditional IRA, contributions are tax-deductible up front. But when you begin withdrawing the money in retirement, you'll then have to pay income taxes on it. With a Roth IRA, you'll pay taxes on the initial contributions, but you'll be able to withdraw the money tax-free during retirement.

Keep in mind that with both types of accounts, if you withdraw before age 59 1/2, you may be subject to penalty fees from the IRS. With a traditional IRA, you'll have to pay a 10% penalty, as well as income taxes on the amount you withdraw. For Roth accounts, because you've already paid taxes on your contributions, you're allowed to withdraw that money without any penalties. However, you will pay a 10% penalty on any of the gains you've earned on the contributions.

Also, with traditional IRAs, you're required to start taking distributions at age 70 1/2 -- because you haven't paid taxes on that money yet, the IRS won't let you hold onto it forever. Roth IRAs don't have required minimum distributions, since your contributions have already been taxed.

There are also income restrictions around who is allowed to even open a Roth IRA. If you're a single filer, you're eligible to contribute the full $6,000 per year allowed (or $7,000 per year if you're 50 or older) if you're earning less than $122,000 per year. For those earning between $122,000 and $137,000, you're able to contribute, but not the entire $6,000. And if you're earning more than $137,000 per year, you're not eligible to contribute to a Roth IRA at all. For those who are married filing jointly, the phase-out starts at $193,000 per year in income, and you're ineligible if you're earning $203,000 per year or more. (Keep in mind, though, that even if you're ineligible for a Roth IRA, you can take advantage of the "backdoor" method by contributing to a traditional IRA and then converting it to a Roth.)

Which one is right for you?

Choosing between a Roth IRA and a traditional IRA may sound like a difficult decision, but for most people, your total savings won't be dramatically affected regardless of which one you choose. That being said, there are some factors that could encourage you to lean one way or the other.

For example, if you're a high earner now, you may choose to go with a traditional IRA to get a bigger deduction now. Then if you're in a lower tax bracket by the time you retire, you'll have to pay less in income taxes. Likewise, if you expect to be earning more money in your later years than you are now, a Roth IRA may be the way to go because you won't need to pay income taxes in that higher tax bracket.

Another scenario that could make the Roth IRA advantageous is if you're planning on continuing to work into your 70s. Because you're required to start making withdrawals from a traditional IRA at age 70 1/2, if you're still working in your 70s, that extra income could potentially push you into a higher tax bracket.

Sometimes, the best option is to not choose between them. There's no rule against opening both a traditional and a Roth IRA, and doing so could help you balance your investments and limit your tax risks. Then once you get closer to retirement and have a better idea of what tax bracket you'll be in, you can decide whether it would be beneficial to make additional contributions to a traditional IRA rather than a Roth IRA, or vice versa.

If you don't have access to a 401(k) through your employer, you may feel like your retirement savings options are limited. But both traditional and Roth IRAs are great choices, and with a wider variety of investing options, they may even be better than a 401(k) in some cases. No matter which account you choose (or if you decide to open one of each), the biggest step is just getting started.

3 Takeaway's From Disney's Annual Shareholder Meeting

While the average annual shareholder meeting typically involves voting on important corporate issues or selecting the board of directors, some are much more entertaining. Disney's (NYSE:DIS) annual shareholder meeting is one such event.

In addition to the necessary corporate business that's transacted, shareholders are treated to a rare opportunity to interact with Disney CEO Bob Iger, watch scenes and trailers from upcoming movies, and get updates on important company initiatives.

Here are three takeaways from Disney's 2019 annual meeting of shareholders. 

Image source: Disney.

A galaxy far, far away

One of the biggest ongoing developments for fans of Disney's theme parks is the opening of Star Wars: Galaxy's Edge at both Disneyland in Anaheim and Disney's Hollywood Studios in Orlando, scheduled to open in 2019. Iger called the upcoming attractions the biggest "single-themed land expansion" ever for the theme parks at a whopping 14 acres each. Guests will be treated to the fictional planet of Batuu, which will feature shops and an open-air marketplace, as well as a chance to pilot the fan-favorite Millennium Falcon in a ride dubbed Smuggler's Run.

Iger revealed the official opening dates of the long-awaited attractions, which will debut on May 31 in Anaheim, and Aug. 29 in Orlando. The company will institute a reservation system for the first several weeks after the launch to handle what is expected to be significant demand. Rise of the Resistance, the second flagship ride in the attraction won't be opened until a later date.

Out of the vault

Fans of some of Disney's time-honored classics have had to wait years for the company to release a film from its "vault" -- a term that applies to its practice of rereleasing each movie "for a limited time," allowing consumers to buy it before "it goes back in the vault." This was part of Disney's marketing campaign back in the 1990s.

The company previously announced that the upcoming Disney+ streaming service would be stocked with movies from the Disney, Pixar, Marvel, and Lucasfilm studios, and ultimately contain content from National Geographic once the acquisition of certain assets of Twenty-First Century Fox (NASDAQ:FOX) (NASDAQ:FOXA) is completed.

Image source: Disney.

In a surprise development, Iger announced that "at some point fairly soon after launch, [Disney+] will house the entire Disney motion picture library." These classics will join the new and original content being created just for the service.

Pay to play

Disney's board of director's recently revised Iger's future pay after The California Public Employees' Retirement System (CalPERS) -- which holds 3.2 million shares of Disney stock -- objected to Iger's compensation package. The board made the rare move of reducing Iger's pay by about $13.5 million. Last year, 52% of shareholders voted against Iger's pay in a vote that was non-binding. In a statement at the time, Aylwin Lewis, the chair of the board's compensation committee, said, "The board accepts the result of today's non-binding vote and will take it under advisement for future CEO compensation." 

The announced reduction was apparently enough to appease the majority of shareholders, as the revised compensation package was approved by 57% of voters.

Salesforce Plans to Double Revenue in Four Years

Expectations were high going into salesforce.com's (NYSE:CRM) fourth-quarter earnings report. The company has a knack for providing conservative guidance that allows it to exceed its own guidance and raise its full-year forecast. Historically, the "beat and raise" has served investors well, but in this case, Wall Street simply shrugged off the results.

For the fourth quarter (which ended Jan. 31), Salesforce reported revenue of $3.6 billion, an increase of 26% year over year and 27% in constant currency. This beat the high end of management's forecasted range, which topped out $3.561, as well as analysts' consensus estimates of $3.56 billion. The bottom line was also better than expected, with non-GAAP earnings per share of $0.70, far exceeding the company's guidance and Wall Street's expectations, both at $0.55. 

Image source: Salesforce.https://brandfolder.com/salesforce

Continued solid results

Subscription and support revenue still pays the lion's share of the bills, coming in at $3.38 billion, up 26% year over year, and up 27% in constant currency. Professional services and other revenue contributes a much smaller portion, growing to $228 million, up 16% compared to the prior-year quarter.

The company saw consistently strong increases across its growing portfolio of products. Revenue from the sales cloud increased 11% year over year to $1.1 billion. Service cloud revenue grew even more, topping $1 billion, up 22% year over year. The two smallest segments enjoyed the largest percentage gains, with the Salesforce platform and other up 54% year over year to $800 million, and the marketing cloud and commerce cloud growing to $500 million, up 34% compared to the prior-year quarter.

Salesforce continued to see solid results in each of the company's geographical regions. The Americas still provides the bulk of the company's business, generating $2.581 billion, up 26% year over year. Sales in Europe, the Middle East, and Africa (EMEA) rose to $677 million, while revenue in the Asia-Pacific region (APAC) climbed to $345 million, each up 25% year over year.

The company's remaining performance obligation, which is made up of future revenue that is under contract but has not yet been recognized, surged to $25.7 billion, up 25% year over year. The portion that will be realized over the coming 12 months jumped to $11.90 billion, an increase of 24% compared to the prior-year quarter.

Great expectations?

On the conference call to discuss the results, chairman and co-CEO Marc Benioff said that for fiscal-year 2023, the company was targeting revenue of $26 billion to $28 billion, compared to the $13.3 billion achieved in 2019, effectively doubling the company's organic revenue over a period of four years. This implies a compound annual growth rate of around 20% -- a significant accomplishment for a company of this size.

Salesforce co-CEO Marc Benioff. Image source: Salesforce.com.

Benioff laid out three reasons why he believes this ambitious goal is achievable. First, he cited the massive and ongoing "movement to the cloud." Second, he pointed to the "digital transformation," or the growing use of digital technology to solve more traditional problems. Third, he said the process begins and ends with the customer, which is right in Salesforce's wheelhouse. Benioff said that the intersection of these three areas, the cloud, digital transformation, and the customer make customer relationship management (CRM) "the most important market in enterprise software." He believes this will work to Salesforce's advantage and help the company to achieve its lofty growth goals.

What the future could hold

Wall Street had no qualms with the numbers Salesforce produced this quarter, but seemed rather unimpressed by what it considered to be weak guidance for the first quarter. Salesforce forecast revenue in the range of $3.67 billion and $3.68 billion, up 22% year over year at the midpoint of its guidance. This fell just shy of analysts' consensus estimates of $3.7 billion. The company is also guiding for adjusted earnings per share of between $0.60 and $0.61, also below expectations of $0.63.

Salesforce is continuing to deliver in all the ways that matter and investors should avoid the temptation to view it in terms of next quarter or even next year. The company is planning to double its revenue to about $27 billion in the coming four years. That's what investors should really be excited about.

Trump reportedly pushing for trade deal with China in hopes of boosting stock market

President Donald Trump is pushing hard to strike a trade deal with China with the hopes of lifting stock market prices further, Bloomberg News reported Wednesday.

The report, which cited people familiar with the matter, said Trump is increasingly concerned that the lack of a trade agreement could knock down stocks. Trump has taken notice of the market's gains as both sides get closer to a deal, the report added.

One of the people familiar with the matter told Bloomberg that Trump watched how U.S. and Asian shares rose following his decision to push back a tariff hike scheduled for March 1.

U.S. stocks came out of the gates strong to start 2019, with the S&P 500 rallying more than 11 percent through Tuesday's close. Part of the rally has been fueled by investors increasing bets that China and the U.S. will strike a trade deal soon. However, there are growing concerns that a deal is fully baked into the market, possibly limiting any more gains coming from positive trade news.

CNBC learned through sources on Monday that China and the U.S. were in the "final stages" of trade talks that could end this month. Sources also said the two sides are working on a Mar-a-Lago summit to cap off the negotiations.

Worries over the two countries' skirmish kept Wall Street on edge for most of last year as investors worried about the impasse's impact on corporate earnings.

The White House did not immediately respond to CNBC's request for comment.

Click here to read Bloomberg News' full report.

Subscribe to CNBC on YouTube.

Top 5 Growth Stocks To Invest In 2019

tags:JWN,TBI,BWLD,ISRG,MED,

CEO & Chairman of Ringcentral Inc (NYSE:RNG) Vladimir Shmunis sold 88,197 shares of RNG on 08/22/2018 at an average price of $89.67 a share. The total sale was $7.9 million.

RingCentral Inc provides software-as-a-service, or SaaS, solutions for business communications. Its solutions can be used in multiple devices including Smartphones, Tablets, PC's and Desk Phones which allows for communication across multiple channels. RingCentral Inc has a market cap of $7.22 billion; its shares were traded at around $90.70 with and P/S ratio of 12.17. RingCentral Inc had annual average EBITDA growth of 30.60% over the past five years.

CEO Recent Trades:

CEO & Chairman, 10% Owner Vladimir Shmunis sold 88,197 shares of RNG stock on 08/22/2018 at the average price of $89.67. The price of the stock has increased by 1.15% since.

Directors and Officers Recent Trades:

COO David Sipes sold 9,300 shares of RNG stock on 07/25/2018 at the average price of $81.13. The price of the stock has increased by 11.8% since.

For the complete insider trading history of RNG, click here

Top 5 Growth Stocks To Invest In 2019: Nordstrom Inc.(JWN)

Advisors' Opinion:

• [By Adam Levine-Weinberg]

  While the Hudson's Bay balance sheet is in better shape now, its underlying operations are far from healthy. First, Lord & Taylor's struggles go far beyond the flagship store that closed last month. The chain has experienced steady erosion of its customer base over the past few decades and has been unable to keep up with trendier rivals like Nordstrom (NYSE:JWN).

• [By Garrett Baldwin]

  Earnings season is well underway. And if you're looking to make real money, the time to get started is now. Money Morning's Quantitative Specialist Chris Johnson argues that the markets are at a tipping point. And with just a few smart plays in today's classic stock picker's market… you can pull in triple digit gains with just a small investment. Read those picks, right here.

  The Top Stock Market Stories for Thursday Wal-Mart Stores (NYSE: WMT) headlines a busy day of earnings reports Today. Shares of WMT stock popped almost 10% after the firm reported its largest domestic sales increase in 10 years. Walmart reported adjusted earnings of $1.29 per share, a figure that topped expectations by 7 cents per share. Revenue also easily beat Wall Street expectations. The firm's positive earnings and revenue numbers helped push its rival Target Corporation (NYSE: TGT) up 3% as well before the bell Thursday. Turkey remains a major geopolitical headache for markets around the globe. The International Monetary Fund issued a statement arguing that the nation must take steps to stabilize its currency and help bring certainty to the global markets. The country's currency (the Lira) is off about 40% this year as markets grow increasingly concerned about the nation's leaders' abilities to stave off inflation. President Tayyip Erdogan's has repeated called for lower interest rates despite clear proof that the nation's currency value is eroding. Four Stocks to Watch Today: NVDA, JCP, BA NVIDIA Corporation (Nasdaq: NVDA) will report earnings after the bell Thursday. Wall Street will be interested to learn the impact of falling Bitcoin and other cryptocurrency prices on the semiconductor giant's bottom line. The average trade estimate for earnings sits at $1.83 per share on top of $3.11 billion in quarterly revenue. A day after news broke that U.S. retail spending was strong in the second quarter, J.C. Penney (NYSE: JCP) shares plunged nearly 22% after the firm reported
• [By Garrett Baldwin]
  Crude oil prices continue to remain in focus after Brent crude hit $80.00 per barrel. The benchmark crude touched $80.00, as markets are concerned about the impact renewed Iranian sanctions will have on global supply. French oil giant Total announced Wednesday that it was abandoning a gas project in Iran after failing to obtain a waiver from the Trump administration to do business in Iran. The sanctions are expected to decline global output at a time that OPEC is already working diligently to push oil prices higher by containing excessive global production. Four Stocks to Watch Today: JCP, BABA, F, KR Shares of JCPenney (NYSE: JCP) are ticking higher after its earnings report before the bell. Yesterday, retail companies were stunned by the 11% jump for its rival Macy's Inc. (NYSE: M) stock thanks to a strong first-quarter report. Alibaba Group Holding Ltd. (NYSE: BABA) is generating a lot of buzz as investors monitor trade relations between the United States and China. BABA stock had slumped by 18% thanks to trade restrictions on Chinese companies. Ford Motor Co. (NYSE: F) announced it will restart production of its popular F-150 pickup truck at its Dearborn, Mich., facility. The company recently suspended operations after a fire damaged supplies needed for manufacturing. The F-150 is the most popular consumer vehicle in the United States. In an effort to beat back the growth of Wal-Mart and Amazon, grocery giant Kroger Co. (NYSE: KR) announced a deal to purchase a 5% stake in British online supermarket Ocado. The deal will allow Kroger to utilize the UK firm's warehouse automation technology in the United States and improve its supply chain costs. Look for additional earnings reports from Applied Materials Inc. (Nasdaq: AMAT), Nordstrom Inc. (NYSE: JWN), The Children's Place Inc. (Nasdaq: PLCE), Teekay Corp. (NYSE: TK), and Quantum Corp. (NYSE: QTM).

  Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top 5 Growth Stocks To Invest In 2019: TrueBlue Inc.(TBI)

Advisors' Opinion:

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Trueblue (TBI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Motley Fool Transcribers]

  TrueBlue Inc  (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Logan Wallace]

  Media stories about Trueblue (NYSE:TBI) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.3296498009881 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

• [By Stephan Byrd]

  Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.

• [By Joseph Griffin]

  Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

Top 5 Growth Stocks To Invest In 2019: Buffalo Wild Wings Inc.(BWLD)

Advisors' Opinion:

• [By Peter Graham]

  A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen's clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby's Restaurant Group:

• [By Steve Symington]

  That's not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

Top 5 Growth Stocks To Invest In 2019: Intuitive Surgical Inc.(ISRG)

Advisors' Opinion:

• [By ]

  As of the time of this article, home cleaning robot maker iRobot's (IRBT) shares are down over 6% on the news. And though it makes surgical robots rather than anything meant for homes, Intuitive Surgical  (ISRG) is down close to 2%. As usual, Wall Street immediately trembles on any sign that Amazon plans to further expand its reach.

• [By Daniel Sparks]

  As earnings season begins to kick into gear, next week features stocks of all shapes and sizes. But two stocks I'll be watching are growth stocks Netflix (NASDAQ:NFLX) and Intuitive Surgical (NASDAQ:ISRG). Both companies are benefiting from double-digit growth in revenue and earnings per share. When these companies report their second-quarter results next week, investors will be watching to see if they can keep executing well on the growth opportunities before them.

• [By Chris Lange]

  The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Intuitive Surgical, Inc. (NASDAQ: ISRG) which rose over 6% to $423.76. The stock's 52-week range is $217.19 to $426.98. Volume was 1.7 million compared to its average volume of nearly 1 million.

• [By ]

  And stocks are following suit. Intuitive Surgical (NASDAQ: ISRG) for example, has been on strong, steady climb for the better part of a year.

• [By Chris Lange]

  The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Intuitive Surgical, Inc. (NASDAQ: ISRG) which rose about 8% to $469.73. The stock's 52-week range is $263.66 to $473.79. Volume was 3.2 million compared to the daily average volume of less than 1 million.

Top 5 Growth Stocks To Invest In 2019: MEDIFAST INC(MED)

Advisors' Opinion:

• [By Ethan Ryder]

  MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.

• [By Lisa Levin] Gainers Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday. Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings. Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744. Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share. Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban. Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results. California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings. Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results. Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance. Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46. Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results. Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter. Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36. Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings. Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result
• [By Logan Wallace]

  MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. MediBloc [QRC20]’s official website is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The official message board for MediBloc [QRC20] is medium.com/@MediBloc. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here.

• [By Sean Williams]

  Meanwhile, Medifast's (NYSE:MED) share price has tripled since the beginning of March. Medifast's second-quarter operating results showcased a 55% increase in sales and an 84% improvement in year-over-year adjusted earnings per share. A substantial increase in Optavia-branded products sold, along with a big jump in active earning coaches, drove results. The company also substantially lifted its full-year sales and profit guidance (close to 20% at the midpoint for both measures). 

• [By Max Byerly]

  McCormick & Company, Incorporated (NYSE: MKC) and Medifast (NYSE:MED) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Caesarstone (CSTE) Lifted to “Hold” at ValuEngine

ValuEngine upgraded shares of Caesarstone (NASDAQ:CSTE) from a sell rating to a hold rating in a report issued on Friday.

Several other equities analysts have also recently commented on CSTE. Zacks Investment Research cut shares of Caesarstone from a hold rating to a sell rating in a report on Thursday, January 3rd. BidaskClub upgraded shares of Caesarstone from a hold rating to a buy rating in a report on Tuesday, November 20th. Finally, Credit Suisse Group set a $12.00 price target on shares of Caesarstone and gave the company a sell rating in a report on Friday, January 11th. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of $16.00.

Get Caesarstone alerts:

Caesarstone stock opened at $17.01 on Friday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.73 and a current ratio of 3.15. Caesarstone has a 12 month low of $12.49 and a 12 month high of $21.80. The firm has a market cap of $585.99 million, a PE ratio of 23.63 and a beta of 1.84.

Caesarstone (NASDAQ:CSTE) last posted its quarterly earnings results on Wednesday, February 6th. The construction company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.10). Caesarstone had a net margin of 4.24% and a return on equity of 5.21%. The company had revenue of $142.88 million for the quarter, compared to analysts’ expectations of $141.16 million. During the same quarter in the prior year, the firm earned $0.22 earnings per share. The company’s revenue was down 3.6% on a year-over-year basis. As a group, equities analysts expect that Caesarstone will post 0.67 earnings per share for the current fiscal year.

Large investors have recently modified their holdings of the stock. Legal & General Group Plc boosted its holdings in Caesarstone by 10.4% in the fourth quarter. Legal & General Group Plc now owns 8,616 shares of the construction company’s stock worth $117,000 after purchasing an additional 813 shares in the last quarter. Nisa Investment Advisors LLC boosted its holdings in Caesarstone by 21.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 8,960 shares of the construction company’s stock worth $122,000 after purchasing an additional 1,600 shares in the last quarter. Marshall Wace North America L.P. bought a new stake in Caesarstone in the third quarter worth $214,000. Bank of America Corp DE boosted its holdings in Caesarstone by 37.1% in the fourth quarter. Bank of America Corp DE now owns 19,742 shares of the construction company’s stock worth $268,000 after purchasing an additional 5,338 shares in the last quarter. Finally, Hartford Investment Management Co. bought a new stake in Caesarstone in the third quarter worth $305,000. Hedge funds and other institutional investors own 48.33% of the company’s stock.

Caesarstone Company Profile

Caesarstone Ltd., together with its subsidiaries, manufactures and sells engineered quartz surfaces under the Caesarstone brand in the United States, Australia, Canada, Israel, Europe, and internationally. Its engineered quartz slabs are used as countertops in residential kitchens, as well as serve the renovation and remodeling market.

Read More: How is net asset value different from market price?

To view ValuEngine’s full report, visit ValuEngine’s official website.